Fentanyl Transdermal Patch, Extended Release
NDC Package 0406-9062-76
Package Information
Fentanyl Transdermal patches is a medication used to help relieve severe ongoing pain (such as due to cancer). This formulation utilizes a patch, extended release delivery system. Marketed by Specgx Llc, this product is identified by NDC 0406-9062 and is authorized under FDA application ANDA077154.
Identification & Billing
- RxCUI: 1603495 - fentaNYL 37.5 MCG/HR 72HR Transdermal System
- RxCUI: 1603495 - 72 HR fentanyl 0.0375 MG/HR Transdermal System
- RxCUI: 1603495 - fentanyl 37.5 MCG/HR 3 Day Transdermal Patch
- RxCUI: 1603498 - fentaNYL 62.5 MCG/HR 72 HR Transdermal System
- RxCUI: 1603498 - 72 HR fentanyl 0.0625 MG/HR Transdermal System
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0406 - Specgx Llc
- 0406-9062 - Fentanyl Transdermal
- 0406-9062-76 - 5 POUCH in 1 CARTON / 1 PATCH in 1 POUCH / 72 h in 1 PATCH
- 0406-9062 - Fentanyl Transdermal
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0406-9062-76 identifies a specific commercial package of 5 pouch in 1 carton / 1 patch in 1 pouch / 72 h in 1 patch of Fentanyl Transdermal, a human prescription drug labeled by Specgx Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This patch, extended release is formulated for transdermal use and contains fentanyl as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Specgx Llc on February 28, 2020. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to help relieve severe ongoing pain (such as due to cancer). Fentanyl belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. Do not use the patch form of fentanyl to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use.
How is this Specgx Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00406906276. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.